Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Mass Spectrometry Systems

By Drug Discovery Trends Editor | October 21, 2008

AB SCIEX mass spec systemsApplied Biosystems and MDS Analytical Technologies introduced the AB SCIEX Triple Quad 5500 and the AB SCIEX QTRAP 5500 mass spectrometry systems for complete workflow solutions.

The new platform includes state-of-the-art electronics, new ion optics architecture, newly-designed components and a 44% smaller footprint than previous systems. These advancements were made to increase sensitivity and speed in qualitative analysis; drive the highest quantitative accuracy to the lowest levels of detection for mass spectrometry systems; and, significantly accelerate the speed of analysis when compared to other instruments, according to the companies.

The AB SCIEX Triple Quad 5500 System is a triple quadrupole mass spectrometry system that surpasses the performance specifications of the API 5000 System. This new level of speed and sensitivity enables a greater amount of data to be acquired from an experiment, which leads to greater quantitative accuracy and lower limits of detection, compared to competitive triple quadrupole instruments. It also features a new pulse-counting detector known as AcQuRate, which effectively detects ions to increase quantitative accuracy and precision. This enables a 5x increase in sensitivity, compared to competitive triple quadrupole instruments.

The AB SCIEX QTRAP 5500 System integrates triple quadrupole capabilities with a new innovation in ion trap technology called Linear Accelerator Trap for quantitative and qualitative analysis. This system integrates all of the features of the AB SCIEX Triple Quad 5500 System, combining them with the new Linear Accelerator Trap technology. It enables scientists to both identify and confirm results in a single analysis. In qualitative mode, the system can provide up to 100 times more sensitivity, depending on the type of experiment. It also delivers ultra-fast scanning and high capacity, provided by the new eQ Electronics as well as the new Linear Accelerator Trap.

Applied Biosystems 
MDS Analytical Technologies  


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE